The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

P-Cttlvc-T     10-(4-aminobutyl)-N-(1- aminocarbonyl-2...

Synonyms: RC-121, AR-1B9973, RC 121, IM 4-28, AC1L2RX7, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of RC 121


High impact information on RC 121

  • When SST-like activities of AN-238 and its carrier, RC-121, were compared in the rat pituitary superfusion system, both compounds were found to suppress a stimulated growth hormone release at nanomolar concentrations [5].
  • We studied the ability of three therapeutically promising radioactively labeled somatostatin octapeptide analogs, RC-160, RC-121, and RC-161, to cross the blood-brain barrier (BBB) after peripheral or central injection [6].
  • The clearance from the CNS of RC-160 and RC-121, but not RC-161, was faster than could be accounted for by reabsorption of cerebrospinal fluid [6].
  • When haloperidol was used to elevate PRL level, a single injection of RC-121 inhibited PRL release in EB-pretreated female rats or untreated female and male rats [7].
  • Control groups of mice received saline, RC-121 or methotrexate [4].

Anatomical context of RC 121

  • Several octapeptide analogs of somatostatin including D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2 (RC-160) and D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (RC-121), which were superactive in tests on suppression of GH levels, were 4-5 times more potent than S-S-14 in inhibiting desglugastrin-stimulated gastric acid secretion in GF dogs [8].

Associations of RC 121 with other chemical compounds

  • Cytotoxic radical AN-201, the unconjugated mixture of somatostatin analogue RC-121 and AN-201 or RC-121 alone had no significant effects [9].
  • Analog D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (RC-121), at a dose of 5 micrograms/100 g body wt, did not decrease basal PRL levels in thiopental-anesthetized female rats, untreated or treated with estrogen benzoate (EB) (8 micrograms/rat) for 5 days [7].
  • The cytotoxic somatostatin (SST) analog, AN-238, consists of a superactive derivative of doxorubicin (DOX), 2-pyrrolino-DOX (AN-201), linked to the SST analog carrier, RC-121 [10].
  • The cytoprotective effect of a highly potent somatostatin (SRIF) analog, RC-121 (H-D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2), was examined in the absolute ethanol-induced gastric erosion model in rat [11].

Gene context of RC 121

  • Blockade of somatostatin receptors by excess RC-121 abolished the effect of AN-238, demonstrating targeting [9].
  • These results indicate that analogs RC-160 and RC-121 possess prolonged and enhanced biological activities, the former analog showing a high selectivity in inhibiting GH and glucagon release in vivo as compared with that of insulin secretion [12].

Analytical, diagnostic and therapeutic context of RC 121


  1. Evaluation of receptors for somatostatin in various tumors using different analogs. Srkalovic, G., Cai, R.Z., Schally, A.V. J. Clin. Endocrinol. Metab. (1990) [Pubmed]
  2. Regression of U-87 MG human glioblastomas in nude mice after treatment with a cytotoxic somatostatin analog AN-238. Kiaris, H., Schally, A.V., Nagy, A., Sun, B., Szepeshazi, K., Halmos, G. Clin. Cancer Res. (2000) [Pubmed]
  3. The binding of bombesin and somatostatin and their analogs to human colon cancers. Radulovic, S.S., Milovanovic, S.R., Cai, R.Z., Schally, A.V. Proc. Soc. Exp. Biol. Med. (1992) [Pubmed]
  4. Cytotoxic analog of somatostatin containing methotrexate inhibits growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice. Radulovic, S., Nagy, A., Szoke, B., Schally, A.V. Cancer Lett. (1992) [Pubmed]
  5. Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. Nagy, A., Schally, A.V., Halmos, G., Armatis, P., Cai, R.Z., Csernus, V., Kovács, M., Koppán, M., Szepesházi, K., Kahán, Z. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]
  6. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin. Banks, W.A., Schally, A.V., Barrera, C.M., Fasold, M.B., Durham, D.A., Csernus, V.J., Groot, K., Kastin, A.J. Proc. Natl. Acad. Sci. U.S.A. (1990) [Pubmed]
  7. Inhibitory effects of somatostatin analogs on prolactin secretion in rats pretreated with estrogen or haloperidol. Karashima, T., Schally, A.V. Proc. Soc. Exp. Biol. Med. (1987) [Pubmed]
  8. Effect of somatostatin analogs on gastric acid secretion in dogs and rats. Schally, A.V., Colaluca, J., Paulson, D., Carter, W.H., Neitzschman, H.R., Lafaye, H., Cai, R.Z. Int. J. Pept. Protein Res. (1990) [Pubmed]
  9. Growth inhibition of experimental non-Hodgkin's lymphomas with the targeted cytotoxic somatostatin analogue AN-238. Keller, G., Engel, J.B., Schally, A.V., Nagy, A., Hammann, B., Halmos, G. Int. J. Cancer (2005) [Pubmed]
  10. Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1. Engel, J.B., Schally, A.V., Halmos, G., Baker, B., Nagy, A., Keller, G. Cancer (2005) [Pubmed]
  11. Protective effect of an orally administered, highly potent somatostatin analog (RC-121) against absolute ethanol-induced hemorrhagic erosions of the rat gastric mucosa. László, F., Pávó, I., Penke, B., Bálint, G.A. Life Sci. (1989) [Pubmed]
  12. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release. Karashima, T., Cai, R.Z., Schally, A.V. Life Sci. (1987) [Pubmed]
  13. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer. Schally, A.V., Redding, T.W. Proc. Natl. Acad. Sci. U.S.A. (1987) [Pubmed]
WikiGenes - Universities